Rapid response in relapsed follicular lymphoma with massive chylous ascites to anti-CD19 CAR T therapy using Piggy Bac: A case report

CD19-directed chimeric antigen receptor (CAR) T cell therapy has been shown to achieve a considerably durable response in patients with refractory or relapsed B cell non-Hodgkin lymphomas, as seen from the results of Zuma-1, Zuma-5, and other clinical trials. Most of these CARs were generated by len...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Lin, Zhicai, Zhang, Faliang, Chen, Xiuxiu, Yang, Yaping, Fu, Xin, Li, Zhong, Sun, Yan, Qian, Qijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752063/
https://www.ncbi.nlm.nih.gov/pubmed/36532014
http://dx.doi.org/10.3389/fimmu.2022.1007210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752063/
https://www.ncbi.nlm.nih.gov/pubmed/36532014
http://dx.doi.org/10.3389/fimmu.2022.1007210

Ejemplares similares